共 189 条
[1]
Klein R(2008)The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study Arch Ophthalmol 126 513-8
[2]
Moss SE(2010)The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia Ophthalmology 117 313-9
[3]
Meuer SM(2019)Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors J Glob Health 9 010427-302
[4]
Klein BE(2008)Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis Invest Ophthalmol Vis Sci 49 4297-12
[5]
Rogers S(2017)New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion J Ophthalmol 2017 4936924-19
[6]
McIntosh RL(2014)The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases Mediators Inflamm 2014 432685-74
[7]
Cheung N(1989)Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1309-9
[8]
Lim L(2014)Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study Ophthalmology 121 209-34
[9]
Wang JJ(2012)Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab Jpn J Ophthalmol 56 165-34
[10]
Mitchell P(2010)Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 248 155-21